News
We aim to bring you the latest news on advances across bioanalysis, including research and technology, mergers and acquisitions, intellectual property, personnel and more.
The team welcomes suggestions for timely, relevant items for inclusion in the news. If you have any news you wish to share on Bioanalysis Zone, please get in contact.
Research institute celebrates 40th anniversaryBarnett Institute marks four decades of research with celebratory conference.
Posted 21/05/2013 (today)
Development of next generation antibody–drug conjugatesPartnership is to utilize Ambrx’s medicinal chemistry technology for the discovery of oncology therapeutics.
Posted 21/05/2013 (today)
Assay technology provider acquires genomic data analysis companyQIAGEN announces acquisition of Ingenuity Systems, Inc for US$105 million cash.
Posted 16/05/2013 (5 days ago)
CRO opens new facility in the USAUK-based contract testing company opens its first North American offices to meet the rising demand for bioanalytical and biosafety services.
Posted 16/05/2013 (5 days ago)
Protein biomarker for the early detection of rheumatoid arthritisDiagnostic service company announces the availability of two new blood tests for aiding the early diagnosis of rheumatoid arthritis.
Posted 16/05/2013 (5 days ago)
New product released for clinical data managementPharmaceutical Product Development introduce their new technology at the ‘Partnerships in Clinical Trials’ conference.
Posted 14/05/2013 (1 week ago)
Discovery of stable and donor-specific breathprintsRecent study reveals unique mass spectrometric signatures of exhaled breath.
Posted 14/05/2013 (1 week ago)
Mobidiag Oy/Ltd. merges with Amplidiag Oy and Genewave SAS to develop diagnostics for infectious diseasesThe newly formed company intends to meet the need for automated and integrated solutions for diagnostic testing of infectious diseases in a clinical setting.
Posted 09/05/2013 (2 weeks ago)
PRA secures grant to employ new graduatesCRO is given grant to employ recent graduates in Kansas state.
Posted 09/05/2013 (2 weeks ago)
Covance continues investment in the Asia Pacific regionSingapore laboratory expansion enhances Covance’s clinical service offerings.
Posted 09/05/2013 (2 weeks ago)
Partnership to promote the Biopharmaceutics Classification SystemIn a recent press release, Absorption Systems have announced a new partnership with Synerzys.
Posted 07/05/2013 (2 weeks ago)
Thermo Fisher Scientific is set to acquire Life Technologies Corporation by 2014Life science company acquisition aims to enhance the capabilities of consumers working in specialty diagnostics, research and applied markets.
Posted 07/05/2013 (2 weeks ago)
Strategic partnership between 908 Devices and IQT908 Devices has partnered with not-for-profit organisation In-Q-Tel to develop new MS analyzers for the intelligence community.
Posted 02/05/2013 (3 weeks ago)
Theradiag gains €1.2 million financial support for the design and implementation of four new diagnostic kitsFinancial support for Theradiag comes as part of CaReNA, a large-scale project to develop RNA-targeting therapeutics and diagnostics for HIV/AIDS and obesity.
Posted 02/05/2013 (3 weeks ago)
Alliance formed between inVentiv Health and Bell Medical SolutionsPartnership allows expansion in the Japanese market.
Posted 02/05/2013 (3 weeks ago)
Chemist wins grant to develop meningitis diagnostic toolUniversity of Texas El Paso (TX, USA) researcher is awarded US$ 419,000 grant to develop rapid, low-cost, meningitis diagnostic device.
Posted 30/04/2013 (3 weeks ago)
Nuclea Biotechnologies forms alliance with Wilex, Inc. to advance personalized treatment for breast cancer sufferersNuclea’s oncologists will have access to Wilex’s biomarker test for monitoring HER-2/neu in breast cancer patients.
Posted 30/04/2013 (3 weeks ago)
How do cancer tumors develop resistance?Scientists have developed a blood test to track the resistance of tumors in real time.
Posted 25/04/2013 (1 month ago)
New microarray developed by Oxford Gene Technology is to facilitate understanding of cancer formation and developmentThe in-depth genomic analysis carried out by the CytoSureTM Cancer +SNP array helps define the genetic nature of a given tumor, enabling the development of more targeted anti-cancer therapies.
Posted 25/04/2013 (1 month ago)
Dementia diagnostic panel launched for treatable dementiaPartnership provides first single blood test for dementia allowing a more personalized treatment strategy.
Posted 25/04/2013 (1 month ago)







